MODERN ANNOTATED CHECKLIST OF RARE MEDICINAL PLANT SPECIES OF THE NORTH KAZAKHSTAN REGION

2026

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.54596/2958-0048-2026-3-90-106
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

At present, there is no modern annotated checklist of rare medicinal plant species of the North Kazakhstan Region (NKR). This study presents extended data profiles of these representatives of the flora, compiled based on the analysis of scientific publications, field research materials, and herbarium collections of university researchers. According to the compiled list, eleven species of rare medicinal plants of the North Kazakhstan Region are identified. Among them, four species belong to the family Ranunculaceae, while one species each belongs to the families Poaceae, Liliaceae, Lythraceae, Droseraceae, and Menyanthaceae; two species belong to the family Orchidaceae. The taxonomic position, morphology, and ecological characteristics of each species are examined. Particular emphasis is placed on their pharmacological properties, confirming their value as sources of biologically active compounds. Special attention is given to the rarity status of the plants and their distribution within the North Kazakhstan Region, reflecting the uniqueness of the forest-steppe and steppe ecosystems of the region. The results of the study highlight the importance of such research as a tool for inventory and legal regulation of plant protection, as well as the need for further investigation of the pharmacological potential of rare species.